Minims (Tetracaine Hydrochloride)

Tetracaine Hydrochloride, the active ingredient in Minims, is a local anesthetic presented as a topical ophthalmic solution for ocular use. It provides reversible surface anesthesia for diagnostic examinations and minor surgical procedures on the eye, acting by blocking nerve impulse transmission.

GNH USA supplies Minims as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Tetracaine Hydrochloride is a topical ocular anesthetic used to temporarily block sensation in the eye.

- Diagnostic eye examinations: provides anesthesia for slit‑lamp biomicroscopy and tonometry. - Minor ocular surgery: enables painless removal of corneal abrasions or foreign bodies. - Intra‑ocular pressure measurement: reduces discomfort during tonometry procedures.

Tetracaine Hydrochloride may cause local ocular reactions.

Common Side Effects: - Burning sensation: mild discomfort upon instillation. - Stinging: transient sharp sensation after application. - Redness: mild conjunctival hyperemia. - Blurred vision: temporary visual disturbance that resolves quickly.

Serious or Rare Side Effects: - Corneal ulceration: development of an ulcer requiring medical attention. - Allergic reaction: swelling, rash, or hives around the eye. - Anaphylaxis: rare systemic allergic response needing emergency care.

When using Minims, consider the following precautions.

- Assess ocular surface: ensure no active infection before use. - Avoid in patients with known hypersensitivity to tetracaine or related anesthetics. - Use only as directed by a qualified eye‑care professional. - Do not exceed recommended frequency; overuse may delay corneal healing. - Monitor for signs of toxicity: persistent pain or visual changes. - Store at room temperature: keep in the original container, protect from light and moisture.

Tetracaine Hydrochloride can interact with other ophthalmic agents.

Major Interactions (Avoid): - Concurrent use of other topical ocular anesthetics: risk of cumulative toxicity. - Combination with corneal healing agents (e.g., corticosteroid eye drops) may impair healing.

Moderate Interactions (Monitor Closely): - Extensive ocular use may lead to systemic absorption interacting with antiarrhythmic drugs. - Use with contact lenses: may increase irritation. - Concurrent ophthalmic antibiotics: monitor for reduced efficacy.